Acurx director granted 2,150 stock options
Acurx Pharmaceuticals director Carl Sailer received a stock option grant tied to his service on the company’s board.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Acurx Pharmaceuticals director Carl Sailer received a stock option grant tied to his service on the company’s board. The award covers 2,150 options for Common Stock at an exercise price of $2.36 per share.
The options were granted as part of Acurx’s Director Compensation Policy and will fully vest on April 20, 2027. Following this award, Sailer holds stock options for 2,150 underlying shares, which are scheduled to expire on April 20, 2036.
Insider Trade Summary
Grant/Award: 2,150 shares
Grant/Award
1 txn
Insider
Sailer Carl
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 2,150 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 2,150 contracts (Direct)
Footnotes (1)
- F1. This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027.
Key Figures
Stock options granted: 2,150 options
Exercise price: $2.36 per share
Options after transaction: 2,150 options
+3 more
6 metrics
Stock options granted
2,150 options
Grant related to service on board of directors
Exercise price
$2.36 per share
Conversion or exercise price for the stock options
Options after transaction
2,150 options
Total derivative securities following the grant
Vesting date
April 20, 2027
Date when options vest under Director Compensation Policy
Expiration date
April 20, 2036
Option expiration if not exercised
Transaction code
A (grant/award acquisition)
SEC Form 4 transaction code description
Key Terms
Stock Option, Director Compensation Policy, vest, Common Stock
4 terms
Stock Option financial
"security_title: "Stock Option" tied to Common Stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Director Compensation Policy financial
"granted pursuant to the Issuer's Director Compensation Policy"
vest financial
"The shares subject to the options shall vest on April 20, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Common Stock financial
"underlying_security_title: "Common Stock" for the option"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Acurx Pharmaceuticals (ACXP) director Carl Sailer report on this Form 4?
Carl Sailer reported receiving a stock option grant for 2,150 shares of Acurx Pharmaceuticals Common Stock. The grant is compensation for his board service and gives him the right to buy shares at a fixed exercise price.
What are the key terms of Carl Sailer’s Acurx (ACXP) stock option grant?
The grant covers 2,150 stock options with an exercise price of $2.36 per share. These options relate to Acurx Common Stock, were awarded for board service, and will expire on April 20, 2036 if not exercised.
When do Carl Sailer’s Acurx (ACXP) stock options vest and become exercisable?
The filing states the 2,150 stock options vest on April 20, 2027. Vesting means they become exercisable on that date, consistent with Acurx’s Director Compensation Policy described in the Form 4 footnote.
How many Acurx (ACXP) stock options does Carl Sailer hold after this transaction?
After this grant, Carl Sailer holds 2,150 stock options linked to Acurx Common Stock, according to the Form 4. This total reflects the options covered by the reported award following the transaction.
Is Carl Sailer’s Acurx (ACXP) stock option grant an open-market purchase or compensation?
The Form 4 shows the transaction as a grant or award acquisition with a price of $0.00 per option. A footnote explains it is compensation under the Director Compensation Policy, not an open-market share purchase.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates